ArticleCancer research2017

Chemotherapeutic Dose Scheduling Based on Tumor Growth Rates Provides a Case for Low-Dose Metronomic High-Entropy Therapies.

Jeffrey West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.